Alfa decongestant eye drops 0.8mg/ml eye drops solution 10ml

In compliance with article 118 "authorization of advertising to the public" of the legislative decree of 24 April 2006, number 219

INDICATIONS

Redness, tearing, burning and itching of the eyes caused by irritative phenomena (excessive exposure to dust, smoke, etc.).

CONTRAINDICATIONS

It should not be used by people with closed-angle glaucoma or other serious eye diseases. Hypersensitivity towards the components or towards other substances closely related from a chemical point of view. It should not be used in children under twelve years of age. Simultaneous treatment with monoamine oxidase inhibitor drugs (see point 4.5).

WARNINGS AND PRECAUTIONS FOR USE

The product, although presenting poor systemic absorption, must be used with caution in patients suffering from hypertension, hyperthyroidism, cardiac disorders, bronchial asthma and hyperglycemia (diabetes). Infections, pus, foreign bodies in the eye, mechanical, chemical, heat damage require medical attention. The product should be kept out of the reach of children as accidental ingestion can cause CNS depression (marked sedation or hypotonia). Since the product, in the 10 ml bottle, contains benzalkonium chloride, soft contact lenses should not be worn during treatment. Since benzalkonium chloride is not present in the single-dose package, this can be used by contact lens wearers, or by those who show hypersensitivity to benzalkonium chloride.

INTERACTIONS

Alfa decongestant eye drops should not be used in subjects undergoing treatment with antidepressant drugs (MAOI) and in the two weeks following such treatment as serious hypertensive crises may arise.

SIDE EFFECTS

The use of the product can sometimes cause pupillary dilation, systemic effects from absorption (hypertension, cardiac disorders, hyperglycemia), increased intraocular pressure, nausea, headache. Rarely, hypersensitivity phenomena may occur. In this case it is necessary to interrupt the treatment and consult the doctor so that, where necessary, suitable therapy can be instituted. The patient is invited to report any undesirable effects not described to the doctor or pharmacist.